Bright Minds Biosciences (DRUG) Net Income Growth (1y) (2024)

Bright Minds Biosciences (DRUG) Net Income Growth (1y) (2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -88.68%
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 13.34%
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -43.69%
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -290.15%
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -73.01%
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -230.18%
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 59.59%
9 Abivax 90.15 Bn 90.15 Bn - -
10 Bright Minds Biosciences 16.28 Bn 16.22 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 102.87%
Jun 30, 2024 116.10%